Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence

European Journal of Neuroscience

Volumn 12, Issue 12, 2000, Pages 4398-4404

  Lu, Lin ^a,b   Liu, Dehong ^a   Ceng, Xiabo ^a   Ma, Lan ^a  

^a FUDAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

helical CRF; 526; AS 30; Conditioned place preference; CP 154; Morphine; Rats

Indexed keywords

ANTISAUVAGINE 30; AS 30; BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; MORPHINE; OPIATE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG EFFECT; IRRITABILITY; JUMPING; LACRIMATION; MALE; NONHUMAN; OPIATE ADDICTION; PLACE PREFERENCE; PRIORITY JOURNAL; PTOSIS; RAT; RECEPTOR UPREGULATION; REFLEX; RELAPSE; WITHDRAWAL SYNDROME;

ANIMALS; CEREBRAL VENTRICLES; CHOICE BEHAVIOR; CORTICOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; INJECTIONS, INTRAVENTRICULAR; MALE; MORPHINE; MORPHINE DEPENDENCE; NALOXONE; PEPTIDE FRAGMENTS; PYRIMIDINES; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0034509832     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2000.01310.x     Document Type: Article

References (47)

1. Conditioned place preference using opiate and stimulant drugs: A meta-analysis
2. Corticotropin-releasing factor antagonist attenuates the 'anxiogenic-like' effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats
3. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: Comparison with CRF1 receptor mRNA expression
4. The role of cholecystokinin (CCK), CCK-A or CCK-B receptor antagonists in the spontaneous preference for drug of abuse (alcohol or cocaine) in naive rats
5. Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: An immunohistochimical study
6. Cloning and characterization of human urocortin
7. The role of 5-HT in the expression of morphine withdrawal in mice
8. The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats
9. Characterization of corticotropin-releasing factor receptor subtypes
10. Differential mechanisms in the acquisition and expression of heroin-induced place preference
11. Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal
12. Learning impairment in transgenic mice with central overexpression of corticotropin-releasing factor
13. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety
14. Role of corticotropin-releasing factor receptor-1 in opiate withdrawal
15. ACTH, cortisol and beta-endorphin response to metyrapone testing during chronic methadone maintenance treatment in humans
16. Corticotropin-releasing factor, stress and behavior
17. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors
18. Differential behavioural effects of chronic infusion of CRH 1 and CRH 2 receptor antisense oligonucleotides into the rat brain
19. Cloning and charaterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain
20. Cholecystokinin-B receptor antagonists attenuate morphine dependence and withdrawal in rats
21. Forced swimming and glucocorticoids facilitate the conditioned place preference induced by morphine in mice
22. Absence of opiate rewarding effects in mice lacking dopamine d2 receptors
23. Regulation of corticotropin-releasing factor type 1 (CRF1) receptor messenger ribonucleis acid in the paraventricular nucleus of rat hypothalamus by exogenous CRF
24. Involvement of dopamine D1 and D2 receptors in the ethanol-associated place preference in rats exposed to conditioned fear stress
25. The role of corticotropin-releasing factor in the anxiogenic effects of ethanol withdrawal
26. Cloning and Functional expression of a rat brain corticotropin-releasing factor (CRF) receptor
27. Glucocorticoids as a biological substrate of reward: Physiological and pathophysiological implications
28. Corticotropin-releasing factor (CRF) and glucocorticoids modulate the expression of type 1 CRF receptor messenger ribonucleic acid in rat anterior pituitary cell cultures
29. Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: Differential role of CRF receptors 1 and 2
30. A selective AMP antagonist, LY293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal
31. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal
32. Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal
33. Structural requirements for pepridic antagonists of the corticotropin-releasing factor receptor (CRFR): Development of CRFR2β selective antisauvagine-30
34. Brain corticotropin-releasing factor mediates anxiety-like behavior induced by cocaine withdrawal in rats
35. Probing alcoholism's 'dark side'
36. CP- 154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats
37. Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats
38. Brain corticotropin-releasing hormone increases arousal in stress
39. Corticotropin-releasing hormone receptor subtypes and emotion
40. Pathways to relapse: The neurobiology of drug- and stress-induced relapse to drug-taking
41. Measuring reward with the conditioned place preference paradigm: A comprehensive review of drug effects, recent progress and new issues
42. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and βendorphin
43. Localization of corticotropin-releasing hormone (CRH) receptor mRNA in adult rat brain by in situ hybridization histochemistry
44. Pharmacodynamics study of antisauvagine-30, an antagonist of corticotropin-releasing factor receptor type 2
45. Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during binge-pattern cocaine administration and chronic withdrawal
46. Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: The first 20 patients treated